Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

5.98USD
30 Jan 2015
Change (% chg)

$-0.27 (-4.32%)
Prev Close
$6.25
Open
$6.21
Day's High
$6.37
Day's Low
$5.97
Volume
228,187
Avg. Vol
309,255
52-wk High
$7.83
52-wk Low
$3.15

PGNX.OQ

Chart for PGNX.OQ

About

Progenics Pharmaceuticals, Inc. (Progenics) is a biopharmaceutical company focuses on research and development for biotechnology product candidates in oncology, virology, supportive care and gastroenterology. It is also engaged in research to identify multiplex phosphoinositide 3-kinase inhibitors for blocking signaling pathways... (more)

Overall

Beta: 1.67
Market Cap(Mil.): $434.72
Shares Outstanding(Mil.): 69.56
Dividend: --
Yield (%): --

Financials

  PGNX.OQ Industry Sector
P/E (TTM): 131.39 39.97 40.64
EPS (TTM): 0.05 -- --
ROI: 5.69 18.85 18.12
ROE: 7.22 19.60 18.97
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00
Provider: S&P Capital IQ Quantitative Report
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks